Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion
| Autor: | Stevenson, J.P. *, DeMaria, D., Sludden, J., Kaye, S.B., Paz-Ares, L., Grochow, L.B., McDonald, A., Selinger, K., Wissel, P., O'Dwyer, P.J., Twelves, C. |
|---|---|
| Zdroj: | In Annals of Oncology March 1999 10(3):339-344 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|